Form 4: Rallybio CEO Reports Stock Transaction
Insider Transaction (Form 4)
Stephen Uden, Chief Executive Officer and a Director of Rallybio Corp, reported multiple transactions in common stock on October 6, 2026.
Summary
- Option exercise/conversion: acquired 22,456 Common Stock at $6.08 ($136,532) on October 6, 2026; holds 115,620 after (Direct).
- Option exercise/conversion: disposed of 22,456 Option (Right to Buy) on October 6, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Stephen Uden — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-06 | Option exercise/conversion | Common Stock | 22,456 | $6 | $136.5K | 115,620 |
| 2026-10-06 | Option exercise/conversion | Option (Right to Buy) | 22,456 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-06 | Option exercise/conversion (22,456 shares) |
| 2026-10-06 | Option exercise/conversion (22,456 shares) |
Keywords
insider transaction, Form 4, RLYB, Rallybio Corp, neutral, Stephen Uden
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.